 |
|
recombinant vaccinia prostate-specific antigen vaccine
A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific antigen vaccine stimulates the host immune system to mount a cytotoxic T-cell response against tumor cells expressing PSA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | Prostate Specific Antigen Expressing Vaccinia Virus Vaccine
rV-PSA
RV-PSA (RECOMB VACCINIA/PSA-CV-1)
rV-PSA vaccine
vaccinia prostate-specific antigen vaccine
vaccinia-prostate-specific antigen vaccine
vaccinia-PSA vaccine | | | | US brand name: | | PROSTVAC | | | | Abbreviation: | | VPSA | | |
| Previous: | recombinant tissue plasminogen activator, recombinant TNF-related apoptosis-inducing ligand, recombinant transforming growth factor-beta-2, recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2 | | Next: | recombinant vaccinia-B7.1 vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine, recombinant vaccinia-MUC-1 vaccine, recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine, recombinant vaccinia-NY-ESO-1 vaccine |
|
|
